- University of Florida College of Medicine, Gainesville
Internship / Residency
- General Surgery - University of Arizona Affiliated Hospitals, Tucson
- PhD, Virology - University of Florida College of Medicine
- American Board of Surgery
- National Board of Medical Examiners
- Research Fellow - National Cancer Institute/National Institutes of Health, Bethesda, MD
- Biological Therapy - University of Pittsburgh Medical Center
- Surgical Oncology - University of Chicago Medical Center
The opportunity to be part of a team of oncologists, pathologists, naturopathic clinicians, dietitians, and many other experts who are focused on fighting cancer attracted Dr. Charles Komen Brown to Cancer Treatment Centers of America® (CTCA). The highly skilled surgical oncologist joined the staff at CTCA in Suburban Chicago in January 2009. Dr. Brown also serves as the hospital’s Medical Director of Surgery.
The surgical oncologist is committed to helping patients with cancer and improving their quality of life. He enjoys getting to know his patients and answering their questions to help them learn about the disease they are fighting. He notes that working within the CTCA® integrated, multidisciplinary setting with dedicated professionals who are driven toward the same goal has been very rewarding.
Prior to joining CTCA, Dr. Brown served as an attending surgeon, assistant professor of surgery and co-director of the surgical oncology fellowship at the University of Pittsburgh. He was also an attending surgeon for the VA Pittsburgh Healthcare System.
After earning a bachelor’s degree in interdisciplinary studies in biological medicine from the University of Florida, he simultaneously completed a PhD in virology and a medical degree at the university.
Dr. Brown completed a residency in general surgery at the University of Arizona Affiliated Hospitals in Tucson, where he served as chief resident in general surgery. He completed fellowships in biological therapy for cancer at the University of Pittsburgh Medical Center and in surgical oncology at the University of Chicago Medical Center. In addition, he garnered experience as a research fellow and clinical associate in surgical oncology at the National Cancer Institute in Bethesda, Maryland. Dr. Brown also has expertise in hyperthermic intraperitoneal chemotherapy (HIPEC), which is a highly concentrated, heated chemotherapy treatment that is delivered directly to the abdomen during surgery. Throughout his career, Dr. Brown has performed over 500 HIPEC surgeries.
Among the accolades Dr. Brown has received are the Federal Executive Board’s Excellence in Government Award for Research, as well as the Robert Baker Golden Apple Award for Excellence in Teaching and the Charles E. Huggins Research Award, both from the University of Chicago’s Department of Surgery. In addition, he has been recognized as one of Castle Connolly's Top Doctors® multiple times (most recently in 2016) and one of its "Top Cancer Doctors" for the United States in 2015 and 2016, lists published in Newsweek. Chicago Magazine also named him to Chicago’s 2016 and 2018 Top Cancer Doctors lists for Surgery. He is board certified by the American Board of Surgery and the National Board of Medical Examiners.
Dr. Brown co-wrote the Holland-Frei Manual of Cancer Medicine published in 2005. He has researched and written extensively on cancer-related subjects, including gene therapy, targeted therapy for melanoma and medical management of melanoma. His work has been published in such renowned clinical publications as Clinical Cancer Research, the Annals of Surgical Oncology and the International Journal of Cancer.
A few of Dr. Brown's published works include:
Dr. Brown is a member of several professional organizations, including the American College of Surgeons, American Association for Cancer Research, Society of Surgical Oncology and the American Society of Clinical Oncology.
Patient ratings and comments
Star ratings and comments are only available for medical oncologists and radiation oncologists. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.